Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types

30 Oct 2012

Abstract excerpt

AIMS: CD44, CD24 and ALDH1 are the most consistently used biomarkers to identify and characterise the breast cancer stem cell (CSC) phenotype. However, most studies performed until now analysed samples of invasive ductal carcinomas of no special type (IDC-NST). Therefore, prevalence and clinical significance of these CSC markers in breast carcinomas of special histological types (SHT) is largely unknown. For that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Lesions and Carcinomas
Share to Cancer Cells and Metastasis
Share to Metastasis and carcinoma case studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23112116
DOI: 10.1136/jclinpath-2012-201169

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological typesPMID 23112116Read ↗

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.Semantic proximity Read ↗

Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinomaSemantic proximity Read ↗

Cancer stem cells and their implication in breast cancer.Semantic proximity Read ↗

Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.Semantic proximity Read ↗

Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.Semantic proximity Read ↗

Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer.Semantic proximity Read ↗

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markersSemantic proximity Read ↗

Breast cancer stem cells: an updateSemantic proximity Read ↗

Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic FactorsSemantic proximity Read ↗

Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo.Semantic proximity Read ↗

Novel molecular regulators of breast cancer stem cell plasticity and heterogeneitySemantic proximity Read ↗

Breast-cancer stem cells-beyond semantics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.